Literature DB >> 33364499

MicroRNA-1911-3p targets mEAK-7 to suppress mTOR signaling in human lung cancer cells.

Daniela Baccelli Mendonça1,2, Joe Truong Nguyen1,2, Fatima Haidar1,2, Alexandra Lucienne Fox1,2, Connor Ray1,2, Halimah Amatullah1,2, Fei Liu1, Jin Koo Kim3, Paul H Krebsbach3.   

Abstract

Regulation of mTOR signaling depends on an intricate interplay of post-translational protein modification. Recently, mEAK-7 (mTOR associated protein, eak-7 homolog) was identified as a positive activator of mTOR signaling via an alternative mTOR complex. However, the upstream regulation of mEAK-7 in human cells is not known. Because microRNAs are capable of modulating protein translation of RNA in eukaryotes, we conducted a bioinformatic search for relevant mEAK-7 targeting microRNAs using the Exiqon miRSearch V3.0 algorithm. Based on the score obtained through miRSearch V3.0, the top predicted miRNA (miR-1911-3p) was studied. miR-1911-3p mimics decreased protein levels of both mEAK-7 and mTORC1 downstream effectors p-S6 and p-4E-BP1 in non-small cell lung carcinoma (NSCLC) cell lines H1975 and H1299. miR-1911-3p levels and MEAK7 mRNA/mEAK-7/mTOR signaling levels were negatively correlated between normal lung and NSCLC cells. miR-1911-3p directly interacted with MEAK7 mRNA at the 3'-UTR to negatively regulate mEAK-7 and significantly decreased mTOR localization to the lysosome. Furthermore, miR-1911-3p significantly decreased cell proliferation and migration in both H1975 and H1299 cells. Thus, miR-1911-3p functions as a suppressor of mTOR signaling through the regulation of MEAK7 mRNA translation in human cancer cells.
© 2020 The Author(s).

Entities:  

Keywords:  Cancer research; Cell biology; Cell migration; Cell proliferation; Gene expression; Gene regulation; Lung cancer; MicroRNA-1911-3p; Oncology; mEAK-7; mTOR signaling

Year:  2020        PMID: 33364499      PMCID: PMC7753913          DOI: 10.1016/j.heliyon.2020.e05734

Source DB:  PubMed          Journal:  Heliyon        ISSN: 2405-8440


  6 in total

1.  CryoEM of endogenous mammalian V-ATPase interacting with the TLDc protein mEAK-7.

Authors:  Yong Zi Tan; Yazan M Abbas; Jing Ze Wu; Di Wu; Kristine A Keon; Geoffrey G Hesketh; Stephanie A Bueler; Anne-Claude Gingras; Carol V Robinson; Sergio Grinstein; John L Rubinstein
Journal:  Life Sci Alliance       Date:  2022-07-06

2.  Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

Authors:  Angelina Huseinovic; Annelieke Jaspers; Annina P van Splunter; Hanne Sørgård; Saskia M Wilting; Dorian R A Swarts; Ida H van der Meulen; Victor W van Beusechem; Renée X de Menezes; Renske D M Steenbergen
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.

Authors:  Peng Yuan; Chaofeng Tang; Bendong Chen; Peng Lei; Jianjun Song; Guojun Xin; Zuozheng Wang; Yongfeng Hui; Weijie Yao; Genwang Wang; Guozhong Zhao
Journal:  Mol Med Rep       Date:  2021-09-01       Impact factor: 2.952

4.  Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer.

Authors:  Vivek Kumar; Sameer Gupta; Amrita Chaurasia; Manisha Sachan
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

Review 5.  mTOR Signaling Components in Tumor Mechanobiology.

Authors:  Antonios N Gargalionis; Kostas A Papavassiliou; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

Review 6.  Medical Aspects of mTOR Inhibition in Kidney Transplantation.

Authors:  Elena Cuadrado-Payán; Fritz Diekmann; David Cucchiari
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.